As part of the Investments for the Future Programs (PIA: Programmes Investissements d'Avenir), the French government has made available €900M for the creation of 14 Technology Transfer Acceleration Companies (SATT).
A SATT is a simplified joint-stock company (SAS: société par actions simplifiée) owned by both academic institutions and the French state. The shareholders of the Lyon Saint-Étienne entity are: the Université de Lyon, the French National Center for Scientific Research (CNRS) and the Caisse des Dépôts.
The principal activity of our SATT consists in selecting and investing in academic research results and transferring them to the socio-economic world. The SATT benefits from a "right of first review" for research results obtained by the Université de Lyon member institutions. These institutions retain ownership of any intellectual property rights attached to their inventions (patents, rights attached to software and knowledge, etc.), and grant the SATT an exclusive license covering these rights, which the company will seek to promote and exploit among businesses, hospitals, regional authorities, etc.
For selected projects, the SATT covers the intellectual property fees, the development costs (proof of concept, demonstrators, prototypes, method consolidation, etc., up to €250,000 per project), and the costs of marketing via already existing companies or, if necessary, helping to set up such a company.
The SATT benefits from a French government-granted subsidy of €57M, which it will use during the 2013-2023 period to accompany and finance transfer projects. It also benefits from regional state funding. At the end of this period, the company is expected to have attained a certain equilibrium allowing it to cover its operating costs and to continue investing in new projects. To this end, the SATT receives a portion of the revenue from licenses (20-50%), as well as commercial revenues.
The SATT works in collaboration with the services or subsidiaries of its institutions, which remain in charge of drawing up and managing the joint research contracts.